Researchers discover potential risk marker for cardiovascular disease in women

FHS
October 3, 2024
11:22 am

Researchers at Karolinska Institutet have identified a new potential risk marker for cardiovascular disease in women.

Biomind Labs Completes the Development of the First 5-MeO-DMT Organic Synthesis Scheme for Pharmaceutical Applications | Psychedelic Invest

Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals

September 14, 2023

Regeneron and Sanofi’s Dupixent bags fifth drug label in Japan – Pharmaceutical Technology

Share this article Dupixent has been approved as a treatment for chronic spontaneous urticaria (CSU) in patients aged 12 and older whose symptoms are inadequately

February 16, 2024

RoboCA3T: A novel robot-inspired computer-assisted adaptive autism therapy

A new study published in the Journal of Computer Assisted Learning introduces a novel Robot-Inspired Computer-Assisted Adaptive Autism Therapy (RoboCA3T) that leverages the natural affinity

May 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.